title: Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
abstract: Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and by topical therapies. This article is the second in a 2-part series of current topical therapeutic options for AKs and discusses topical diclofenac, colchicine, and retinoids. The first part focused on topical 5-fluorouracil and imiquimod.
authors.affiliation: University of Vermont, Burlington, USA. william.tutrone@uvm.edu
authors.forename: William D
authors.initials: WD
authors.lastname: Tutrone
authors.forename: Ritu
authors.initials: R
authors.lastname: Saini
authors.forename: Selin
authors.initials: S
authors.lastname: Caglar
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Weinberg
authors.forename: Jorge
authors.initials: J
authors.lastname: Crespo
mesh_terms: D000279:Administration, Cutaneous; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use*; D004008:Diclofenac / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007642:Keratosis / Q000188:drug therapy* / Q000473:pathology; D011230:Precancerous Conditions / Q000188:drug therapy / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012176:Retinoids / Q000008:administration & dosage / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D007641:Keratolytic Agents; D012176:Retinoids; D004008:Diclofenac; D003078:Colchicine